Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

1 Unprofitable Stock Worth Your Attention and 2 We Avoid

By: StockStory

July 23, 2026 at 00:34 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PL Cover Image

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Unprofitable companies face an uphill battle, but not all are created equal. Luckily for you, StockStory is here to separate the promising ones from the weak. That said, here is one unprofitable company investing heavily to secure market share and two that may never reach the Promised Land.

Two Stocks to Sell:

Azenta (AZTA)

Trailing 12-Month GAAP Operating Margin: -28.8%

Serving as the guardian of some of medicine's most valuable materials, Azenta (NASDAQ: AZTA) provides biological sample management, storage, and genomic services that help pharmaceutical and biotechnology companies preserve and analyze critical research materials.

Why Should You Sell AZTA?

Sales tumbled by 4.3% annually over the last two years, showing market trends are working against it during this cycle
Earnings per share have contracted by 24.8% annually over the last five years, a headwind for returns as stock prices often echo long-term EPS performance
Cash-burning history makes us doubt the long-term viability of its business model

Azenta is trading at $27.32 per share, or 45.6x forward P/E. Read our free research report to see why you should think twice about including AZTA in your portfolio.

Peabody Energy (BTU)

Trailing 12-Month GAAP Operating Margin: -4%

Beginning with a single wagon hauling coal in Illinois back when Grover Cleveland was president, Peabody Energy (NYSE: BTU) mines coal used by electricity generators and steel manufacturers.

Why Is BTU Risky?

Customers postponed purchases of its products and services this cycle as its revenue declined by 2.7% annually over the last ten years
Gross margin of 24.9% reflects its high production costs and unfavorable asset base
Expenses have increased as a percentage of revenue over the last five years as its EBITDA margin fell by 25.1 percentage points

At $23.99 per share, Peabody Energy trades at 12x forward P/E. To fully understand why you should be careful with BTU, check out our full research report (it’s free).

One Stock to Buy:

Planet Labs (PL)

Trailing 12-Month GAAP Operating Margin: -31.9%

Pioneering the concept of "agile aerospace" with hundreds of small but powerful satellites, Planet Labs (NYSE: PL) operates the world's largest fleet of Earth observation satellites, capturing daily images of our planet to provide insights on deforestation, agriculture, and climate change.

What Makes PL Stand Out?

Backlog has averaged 143% growth over the past two years, showing it has a pipeline of unfulfilled orders that will support revenue in the future
Incremental sales significantly boosted profitability as its annual earnings per share growth of 48.9% over the last two years outstripped its revenue performance
Free cash flow flipped to positive over the last five years, showing the company has crossed a key inflection point

Planet Labs’s stock price of $22.41 implies a valuation ratio of 376.7x forward EV-to-EBITDA. Is now the right time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	233.66	-11.19 (-4.57%)
AAPL	321.66	-4.23 (-1.30%)
AMD	539.69	-12.64 (-2.29%)
BAC	61.28	-0.34 (-0.55%)
GOOG	318.34	-23.57 (-6.89%)
META	606.10	-21.07 (-3.36%)
MSFT	381.58	-8.76 (-2.24%)
NVDA	208.76	-3.30 (-1.56%)
ORCL	120.04	-5.80 (-4.61%)
TSLA	319.69	-54.32 (-14.52%)